Bumper Offer - Urjas oil Just @ Rs. 1
Rosumac ASP Capsule, a prescription drug, is manufactured in various forms such as Capsule. Rosumac ASP Capsule also has some secondary and off-label uses. These are listed below.
The right dosage of Rosumac ASP Capsule depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Some other side effects of Rosumac ASP Capsule have been listed ahead. Usually, these side effects of Rosumac ASP Capsule go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Rosumac ASP Capsule's effect during pregnancy is Severe and Severe while nursing. In addition, Rosumac ASP Capsule's effects on the liver, heart and kidney are discussed below in the Rosumac ASP Capsule related warnings section.
Rosumac ASP Capsule can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rosumac ASP Capsule in conditions like Kidney Disease, Hypothyroidism, Drug Allergy. Other conditions have been mentioned below in the Rosumac ASP Capsule contraindications section.
Besides this, Rosumac ASP Capsule may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Rosumac ASP Capsule is considered safe while driving, and is addictive.
Rosumac ASP Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Rosumac ASP Capsule is used -
Severe
Moderate
Mild
Is the use of Rosumac ASP Capsule safe for pregnant women?
Rosumac ASP should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Rosumac ASP Capsule safe during breastfeeding?
Taking Rosumac ASP may lead to serious side effects if you are breastfeeding. Rosumac ASP should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Rosumac ASP Capsule on the Kidneys?
Rosumac ASP can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Rosumac ASP Capsule on the Liver?
Rosumac ASP is completely safe for the liver.
What is the effect of Rosumac ASP Capsule on the Heart?
There may be an adverse effect on the heart after taking Rosumac ASP. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Rosumac ASP Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Rosumac ASP Capsule unless your doctor advises you to do so -
Is this Rosumac ASP Capsule habit forming or addictive?
Rosumac ASP Capsule does not cause addiction.
Interaction between Food and Rosumac ASP Capsule
There isn't any research available on the side effects of taking Rosumac ASP Capsule with food.
Interaction between Alcohol and Rosumac ASP Capsule
It is difficult to say anything about the effect of Rosumac ASP Capsule and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
